Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zvia Agur

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Future Oncology (London, England)|June 10, 2010
From the evolution of toxin resistance to virtual clinical trials: the role of mathematical models in oncologyZvia Agur
Croatian Medical Journal|April 30, 2014
The resonance phenomenon in population persistence: can the same theory guide both national security policies and personalized medicine?Zvia Agur
Future Oncology (London, England)|March 25, 2006
Biomathematics in the development of personalized medicine in oncologyZvia Agur
Oncoimmunology|November 22, 2012
Personalizing immunotherapy: Balancing predictability and precisionZvia Agur, Stanimir Vuk-Pavlović
Journal of Mathematical Biology|April 11, 2002
The universal properties of stem cells as pinpointed by a simple discrete modelZvia Agur, Yoaz Daniel, Yuval Ginosar
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|March 8, 2014
Personalizing oncology treatments by predicting drug efficacy, side-effects, and improved therapy: mathematics, statistics, and their integrationZvia Agur, Moran Elishmereni, Yuri Kheifetz
Cancer Research|July 20, 2006
Cancer immunotherapy by interleukin-21: potential treatment strategies evaluated in a mathematical modelAntonio Cappuccio, Moran Elishmereni, Zvia Agur
Journal of Theoretical Biology|June 19, 2007
Optimization of interleukin-21 immunotherapeutic strategiesAntonio Cappuccio, Moran Elishmereni, Zvia Agur
Journal of Pharmacokinetics and Pharmacodynamics|September 19, 2014
Complex pattern of interleukin-11-induced inflammation revealed by mathematically modeling the dynamics of C-reactive proteinYuri Kheifetz, Moran Elishmereni, Zvia Agur
Frontiers in Immunology|March 18, 2021
A New Method for Optimizing Sepsis Therapy by Nivolumab and Meropenem Combination: Importance of Early Intervention and CTL Reinvigoration Rate as a Response MarkerAvi Gillis, Anat Ben Yaacov, Zvia Agur
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Future Oncology (London, England)|June 10, 2010
From the evolution of toxin resistance to virtual clinical trials: the role of mathematical models in oncologyZvia Agur
Croatian Medical Journal|April 30, 2014
The resonance phenomenon in population persistence: can the same theory guide both national security policies and personalized medicine?Zvia Agur
Future Oncology (London, England)|March 25, 2006
Biomathematics in the development of personalized medicine in oncologyZvia Agur
Oncoimmunology|November 22, 2012
Personalizing immunotherapy: Balancing predictability and precisionZvia Agur, Stanimir Vuk-Pavlović
Journal of Mathematical Biology|April 11, 2002
The universal properties of stem cells as pinpointed by a simple discrete modelZvia Agur, Yoaz Daniel, Yuval Ginosar
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|March 8, 2014
Personalizing oncology treatments by predicting drug efficacy, side-effects, and improved therapy: mathematics, statistics, and their integrationZvia Agur, Moran Elishmereni, Yuri Kheifetz
Cancer Research|July 20, 2006
Cancer immunotherapy by interleukin-21: potential treatment strategies evaluated in a mathematical modelAntonio Cappuccio, Moran Elishmereni, Zvia Agur
Journal of Theoretical Biology|June 19, 2007
Optimization of interleukin-21 immunotherapeutic strategiesAntonio Cappuccio, Moran Elishmereni, Zvia Agur
Journal of Pharmacokinetics and Pharmacodynamics|September 19, 2014
Complex pattern of interleukin-11-induced inflammation revealed by mathematically modeling the dynamics of C-reactive proteinYuri Kheifetz, Moran Elishmereni, Zvia Agur
Frontiers in Immunology|March 18, 2021
A New Method for Optimizing Sepsis Therapy by Nivolumab and Meropenem Combination: Importance of Early Intervention and CTL Reinvigoration Rate as a Response MarkerAvi Gillis, Anat Ben Yaacov, Zvia Agur
Pageof 4